Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Surveys and Questionnaires × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 3 Rectal Neoplasms 2 Osteosarcoma 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Depression 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Support of the Family as a Caregiving System 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Peripheral Arterial Disease 1 Ovarian Neoplasms 1 Obesity 1 Newly Diagnosed Cancer of the Oropharynx, Oral Cavity, Colon or Liver 1 Neoplasms 1 Motor Activity 1 Melanoma 1 Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia 1 Laryngeal Diseases 1

Interventions

Specimen Handling 3 Magnetic Resonance Spectroscopy 3 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 cabozantinib 1 belzutifan 1 atezolizumab 1 X-Rays 1 Temozolomide 1 Sunitinib 1 Phantoms, Imaging 1 LY2940680 1 Interleukin-13 1 Immunoglobulin G 1 Fluorodeoxyglucose F18 1 Everolimus 1 Disulfides 1 Cyclophosphamide 1 Capecitabine 1 Biopsy 1 Bevacizumab 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡